CRNX — Crinetics Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Crinetics Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	171	334	334	559	1,354
Net Total Receivables	1.83	1.48	2.29	9.1	8.39
Prepaid Expenses
Total Other Current Assets
Total Current Assets	177	345	345	574	1,375
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.41	4.72	4.99	57.4	55.6
Long Term Investments
Other Long Term Assets
Total Assets	183	351	352	635	1,435
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.5	16	27.7	43.9	59.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.5	19.1	35.8	96.2	110
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	169	332	316	539	1,325
Total Liabilities & Shareholders' Equity	183	351	352	635	1,435
Total Common Shares Outstanding